Prof Kevin Winthrop from Oregon Health & Science University. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition Prof Kevin Winthrop discusses the long-term effectiveness of the live zoster vaccine.

The global effort improving patient outcomes amid COVID-19. Past President of EULAR Prof Johannes Bijlsma discusses global rheumatology registries for COVID-19 with EULAR registry group member Prof Kimme Hyrich.

COVID-19 guidance for rheumatologists. Prof Peter Nash discusses the challenges COVID-19 poses with infections specialist Prof Kevin Winthrop.

First to identify destructive properties of IL-17 and received the prestigious Carol Nachman prize in 2010 for his contribution. In this podcast, Prof Pierre Miossec discusses the pathophysiology of RA alongside Prof Tsutomu Takeuchi from Keio University. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Timo Gaber and Paula Hoff from Charité Berlin. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, the impact of tofacitinib on the bone healing process is discussed.

Prof Schett from University of Erlangen-Nuremberg. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Prof Schett discusses how JAK inhibitors can increase bone formation by stimulating osteoblasts.

Prof Iain McInnes discusses bone homeostasis. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Muirhead Professor of Medicine, President of EULAR, and Sir James Black Prize Medal winner. In this podcast, Prof Iain McInnes discusses the inception of JAK inhibitors during his time at the National Institutes of Health with Prof Peter Nash from the University of Queensland. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Dr Giovanni Orsolini from the University of Verona. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Dr Giovanni Orsolini discusses the potential of JAK inhibitors to halt bone erosion, independent of their effects on inflammation.

Prof Iain McInnes discusses JAK selectivity. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Head of the Division of Rheumatology at Karolinska Institute and a co-author of more than 100 articles in peer review journals. In this podcast, Prof Anca Catrina discusses the role of antibodies in the pathogenesis of RA with Prof Johannes Bijlsma from University Medical Centre, Utrecht. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Prof Vibeke Strand from Stanford University. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Vibeke Strand discusses improvements in patient-reported outcomes with upadacitinib.

Iain McInnes discusses patient-reported outcomes. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Member of the US Centers for Disease Control and a co-author of more than 100 publications. In this podcast, Prof Kevin Winthrop discusses the impact concomitant treatments have on HZ risk with Professor Maurizio Cutolo from the University of Genova. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Professor McInnes presents the most notable papers of 2019. You can find detailed summaries of the papers highlighted on http://www.cytokinesignalling.com/en/publications/review-article/511/

Professor McInnes presents the monthly podcast reviewing a paper by Professor Ying‐Chou Chen and another paper by Professor Genovese.

Professor McInnes presents the monthly podcast reviewing a paper by Dr Katie Bechman and another paper by Professor Lee YH.

In this edition of Congress Author Podcasts, recorded at ACR 2019, the latest data from the FINCH studies are presented by Professors Taylor, Westhovens and Winthrop, in addition to filgotinib safety data from a phase 2 Psoriatic Arthritis trial, presented by Professor Coates.

In this edition, recorded at ACR 2019, real-world tofacitinib safety data is presented by Professor Kremer and the impact of baricitinib and tofacitinib on pain is analysed by Professors Taylor and Dougados

In this edition experts, including Professor Smolen and Professor McInnes, present the latest data for the recently approved JAK inhibitor, upadacitinib. The presentations include: data from the SELECT trials, safety analyses, switching from TNF inhibitors, and the mode of action of upadacitinib.

Professor Calabrese introduces highlights from Day 4 of ACR 2019

Professor Calabrese introduces highlights from Day 3 of ACR 2019

Professor Calabrese presents highlights from Day 2 of ACR 2019

Professor Kevin Winthrop introduces the key abstracts from Day 1 at ACR 2019

Professor McInnes presents the monthly podcast reviewing a paper by Professor Bruno Fautrel and another paper by Professor Christina Charles-Schoeman.

Prof McInnes presents the monthly podcast reviewing a paper he authored along with colleagues and another paper by Dr Mori Shunsuke.

Professor Nash Interviews Professor Fleischmann from the University of Texas Southwester Medical Center, about his two recently published papers on upadacitinib.

Professor Nash Interviews Professor Leonard Calabrese from the RJ Fasenmyer Center for clinical Immunology, about his paper examining the live zoster vaccine in patients treated with tofacitinib monotherapy, tofacitinib with MTX and adalimumab with MTX.

Professor Iain McInnes joined by Professor Johannes Bijlsma, discusses the changes required to educate the next generation of rheumatologists, highlighting the benefits of online educational courses and the importance of quality amid a plethora of information.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Fleischmann and Professor Takeuchi.

Professor Nash interviews Dr Roland Grenningloh from the EMD Serono Research and Development Institute, about his paper describing the PK modelling of the novel Bruton’s tyrosine kinase (BTK) inhibitor, evobrutinib, in disease models for RA and lupus.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Tanaka and Professor Calabrese.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Josef Smolen and Professor Wenhui Xie, respectively.

Professor Nash interviews Professor Kevin Winthrop from Oregon Health Sciences University, Portland or USA, about his paper investigating pneumococcal and tetanus vaccine responses in patients with RA receiving baricitinib treatment.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Winthrop K and Professor Wollenhaupt J, respectively

Professor Nash interviews Professor Bernard Combe from the University of Montpellier, France, about a letter investigating the safety of baricitinib treatment in patients with select comorbidities.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Combe B and Dr. Zhang Z, respectively

Professor Nash interviews Professor Tsutomu Takeuchi from Keio University School of Medicine, about the paper looking at safety profile of baricitinib in Japanese patients.

Professor McInnes reviews key abstract from ACR 2018, relating to pain and JAK inhibitors.

Prof McInnes presents the monthly podcast reviewing two papers from Dr. Chengfeng Qiu and Dr. Camean-Castillo, respectively

Professor Nash interviews Professor Peter Taylor from the University of Oxford, about his paper looking at effects of baricitinib on lymphocyte subsets in rheumatoid arthritis

Prof McInnes presents the monthly podcast reviewing two papers from Prof Peter Taylor and van der Heijde, respectively

Prof McInnes presents the monthly podcast reviewing two papers from Prof Tanaka and Kivitz, respectively

Prof McInnes presents the monthly podcast reviewing two papers from Head of Clinical Pharmacology at Galapagos, Florence Namour, and Prof van Vollenhoven

Professor Nash interviews Florence Namour from Galapagos about her recent paper: Influence of Age and Renal Impairment on the Steady State Pharmacokinetics of Filgotinib, a Selective JAK1 Inhibitor

Prof McInnes presents the monthly podcast reviewing two papers from Prof van Vollenhoven and Prof Curtis

Professor Nash interviews Professor Curtis about his recent paper: Herpes zoster in Tofacitinib: Risk is Further Increased with Glucocorticoids but not Methotrexate

Dr Tracy Lovatt, Scientific Director for CESAS Medical, interviews ACR poster authors; Dr Litman, Dr Dominguez-Casas, Professor Fleischmann, Dr Mirza, Professor Taylor, Professor Kivitz and Dr Kunder.